ALERGOTEST s.c., Specjalistyczne Centrum Medyczne Andrzej Emeryk, Małgorzata Bartkowiak-Emeryk

At ALERGOTEST s.c., Specjalistyczne Centrum Medyczne Andrzej Emeryk, Małgorzata Bartkowiak-Emeryk in Lublin, clinical research focuses on allergic and respiratory conditions, with studies aiming to improve symptom control, reduce flare-ups, and support better day-to-day management for children and adults.

• Research in allergic rhinoconjunctivitis and house dust mite allergy, including trials testing whether immunotherapy can relieve nasal and eye symptoms more effectively than placebo.
• Studies in birch pollen-induced allergic rhinoconjunctivitis that evaluate whether allergy treatment can lessen symptoms and reduce the need for rescue medication in younger patients.
• Clinical work in asthma exploring new ways to improve rescue treatment and help lower the risk of severe breathing-related episodes.

The site is also involved in pediatric research on allergy medicines and preventive approaches for respiratory tract infections, reflecting a strong interest in both treatment effectiveness and everyday quality of life.

A major part of the trial portfolio at this health care site examines allergic rhinoconjunctivitis and asthma, with a clear emphasis on finding therapies that can better control symptoms and improve comfort for patients living with chronic airway disease.

• Trials of subcutaneous immunotherapy for moderate to severe allergic rhinitis/rhinoconjunctivitis caused by house dust mite allergy.
• Studies in children and adolescents with birch pollen-induced rhinoconjunctivitis, assessing whether treatment can ease seasonal allergy burden.
• Research in asthma looking at better rescue treatment options and their ability to reduce severe symptoms.

These studies are designed to test treatment effectiveness in real-world allergy and breathing disorders, while also supporting safer and more practical care for younger patients.

Another important area of research at the site concerns respiratory tract infections in children, where investigators are evaluating whether preventive treatment can lower infection rates over the colder months.

• Studies focused on reducing the incidence of respiratory tract infections in children aged 3 to 12 years.
• Research aimed at testing whether a sublingual tablet can help protect children during the fall and winter period.
• Pediatric work that looks at both infection prevention and the broader impact on family and child well-being.

This line of research highlights the site’s interest in preventive medicine and in approaches that may reduce the burden of common seasonal illnesses in everyday pediatric care.